ArticleScience advances2020

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy.

Zhaoting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.